Cargando…
Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Obstructive respiratory diseases like asthma and chronic obstructive pulmonary disease (COPD) are currently treated by inhaled anti-inflammatory and bronchodilator drugs. Despite the availability of multiple treatments, both diseases are growing public health concerns. The majority of asthma patient...
Autores principales: | Phillips, Jonathan E., Zhang, Xuxia, Johnston, James A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MyJove Corporation
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564474/ https://www.ncbi.nlm.nih.gov/pubmed/28448027 http://dx.doi.org/10.3791/55454 |
Ejemplares similares
-
Adapting the Aerogen Mesh Nebulizer for Dried Aerosol Exposures Using the PreciseInhale Platform
por: Gerde, Per, et al.
Publicado: (2020) -
Colistin dry powder inhalation with the Twincer™: An effective and more patient friendly alternative to nebulization
por: Akkerman-Nijland, A. M., et al.
Publicado: (2020) -
Amorphicity and Aerosolization of Soluplus-Based Inhalable Spray Dried Powders
por: Adhikari, Bishal Raj, et al.
Publicado: (2022) -
Inhaled medical aerosols by nebulizer delivery in pulmonary
hypertension
por: Mansour, Heidi M.
Publicado: (2018) -
Evaluation of systemic absorption and bronchodilator effect of glycopyrronium bromide delivered by nebulizer or a dry powder inhaler in subjects with chronic obstructive pulmonary disease
por: Leaker, Brian R., et al.
Publicado: (2019)